Newer data around higher maintenance doses has shown potential weight loss results reaching up to 21% over a longer period
Weight regain after stopping GLP-1 class drugs is well-documented, and sudden cessation at high doses can cause a sharp return of appetite and rapid weight rebound
[PubMed] Hathaway CK, Agarwal N, Planas LG, et al
Most insurers provide coverage for type 2 diabetes with prior authorization (PA), but do not cover weight loss drugs
Igor Wanko Mboumi, MD, FACS, a bariatric and general surgeon at Franciscan Physician Network Indy Southside Surgical in Indianapolis, explains how bariatric surgery and GLP-1 medications can promote weight loss
Recent developments in GLP-1RA therapy: a review of the latest evidence of efficacy and safety and differences within the class